Evaluating Allergic Rhinitis in the Convenient Health Care Clinic: Treatment Strategies for Clinicians and Pharmacists

This activity is supported by an educational grant from McNeil Consumer Healthcare Division.


Jennifer Chan Marcelo, PharmD, BCACP
Clinical Pharmacist, Ambulatory Pharmacy Services
Clinical Assistant Professor, Pharmacy Practice
Assistant Residency Program Director, UIC Community
Pharmacy Residency Program
University of Illinois Hospital and Health Sciences System
University of Illinois at Chicago-College of Pharmacy
Chicago, Illinois
Marlowe Djuric Kachlic, PharmD
Clinical Pharmacist
Clinical Assistant Professor, Experiential Education
Director, UIC Community Pharmacy Residency Program
University of Illinois Hospital and Health Sciences System
University of Illinois at Chicago - College of Pharmacy
Chicago, Illinois

Educational Objectives:

At the completion of this activity, the participant will be able to:
  • Identify symptoms and severity of allergic rhinitis
  • Examine the mechanisms of action, delivery methods, efficacy, and safety for available treatment options
  • Distinguish when to refer to a specialist if immunotherapy is required
  • Explore strategies that incorporate a collaborative care approach in treatment of allergic rhinitis

Statement of Need

Allergic rhinitis affects 19.1 million adults and 6.1 million children in the United States. It can significantly affect the quality of life for patients. Many treatments for allergic rhinitis are available without a prescription and lend themselves to self-care. As patients increasingly use convenient care clinics, it is important for clinicians to collaborate with pharmacists for treatment selection, counseling, and follow-up.
Target audience: Advanced practice nurses, nurse practitioners, and physician assistants working in convenient care clinics.
Activity Type: Application
Release date: August 15, 2016
Expiration date: August 15, 2018
Estimated time to complete activity: 1.0 hour
Fee: Free
This activity is jointly provided by Dannemiller and Pharmacy Times Continuing Education.

Accreditation Statement

This activity has been panned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and ArcMesa Educators. Dannemiller is accredited by ACCME to provide continuing medical education for physicians.
Dannemiller designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)TM from organizations accredited by ACCME.

https://arcmesa.s3.amazonaws.com/_media/_photos/AANP.pngDannemiller is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 090419.
This program is accredited for 1.0 contact hour which includes 1.0 hour of pharmacology.

Method of Participation

To receive credit, all participants will need to read the objectives and other introductory CME/CE information, take the pretest, and then proceed to the educational activity. Once the activity is completed along with the posttest and the evaluation, participants can request credit.
You will have access to your certificate immediately following completion of the evaluation. Credit is provided until August 15, 2018. No credit will be given after this date. There is no fee to participate in this activity.
In the event you have questions about this activity or are unable to retrieve the certificate, please email cme@dannemiller.com, and a certificate will be emailed to you within 2 weeks.

System Requirements for Completion of Posttest and Evaluation

Computer or smartphone with Internet access Web Browser (IE 7.0+ or Webkit/Mozilla Compatible) with JavaScript enabled.


The following contributors have no relevant financial relationships with commercial interests to disclose:
Jennifer Chan Marcelo, PharmD, BCACP
Marlowe Djuric Kachlic, PharmD
Contemporary Clinic Editorial Staff—Kirk McKay, Katie Eder
Pharmacy Times Continuing Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Tara DeLorenzo
Dannemiller Planning Staff—Jennifer Hodge
An anonymous peer reviewer was part of the content validation and conflict resolution and has no relevant financial relationships with commercial interests to disclose. 

Off-Label Statement

This educational activity may contain discussion of published or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Furthermore, attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Contemporary Clinic, ArcMesa Educators, and Dannemiller. This material is prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By